Havva Yeşil Çınkır

19PUBLICATIONS
210CO-AUTHORS
Gene expression (incl. microarray and other genome-wide approaches)Cancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsLiquid biopsiesPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (19)

|Oct 26, 2026
Evaluating the Prognostic Significance of the H-Index and Systemic Inflammatory Parameters in IDH-Wildtype Glioblastoma Survival.

|Jul 15, 2026
Real-World Treatment Outcomes After Nivolumab Progression in BRAF-Negative Metastatic Melanoma: A Multicenter Cohort Study by the Turkish Oncology Group.

|Jun 25, 2026
Real-World Outcomes of CDK4/6 Inhibitors in Germline BRCA1/2-Mutated Hormone Receptor-Positive, HER2-Negative Metastatic Breast Cancer: Turkish Oncology Group (TOG) Study.

|May 08, 2026
Comparison of flat-dose versus weight-based dose nivolumab treatment in NSCLC patients.

|Apr 14, 2026
Baseline vitamin D status and clinical outcomes in advanced non-small cell lung cancer patients treated with nivolumab.

Gözde Ağdaş, Duygu Bayir, Elif Şahin

|Mar 28, 2026
Tyrosine Kinase Inhibitor Therapy in Metastatic Medullary Thyroid Carcinoma: Real-World Data from Turkish Oncology Group.

Sedat Yıldız, Hacer Demir, Talha Özüdoğru

Pageof 4

Frequent Collaborators

7 joint publications

Deniz Can Guven

6 joint publications

Elif Sahin

5 joint publications

Teoman Sakalar

5 joint publications

Nargiz Majidova